Clinical Trials Browser

Phase 1/2 × Granulocyte-Macrophage Colony-Stimulating Factor × 90 days × Clear all

NCT00458536 2026-05-19

Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF

Phase 1/2 Completed

38 enrolled 4 charts

Kidney Neoplasms